Follow-up study of patients with rheumatoid arthritis who treated infliximab for 1 year and did not reach a clinical remission in RRRR Study
Not Applicable
- Conditions
- Rheumatoid Arthritis
- Registration Number
- JPRN-UMIN000007539
- Lead Sponsor
- niversity of Occupational and Environmental Health, Japan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 108
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients who discontinued IFX treatment prior to 54 week from the first administration of IFX in the RRRR Study 2) Patients who are inadequate to enter this trial due to the other reasons by physician's judgments
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Proportion of clinical remission 1 year after enrolling in RRRR-RX Study
- Secondary Outcome Measures
Name Time Method